Abstract
Leptin, the product of the adipose specific ob gene, regulates food intake and energy expenditure. However, little is known about the effects of thyroid status on plasma leptin levels in women. We determined fasting plasma leptin levels before and 1 month after restoration of euthyroidism in 20 female patients with hypothyroidism, 20 female patients with hyperthyroidism and 20 age and BMI — matched female controls. To restore the normal thyroid function patients with hypothyroidism were treated with levothyroxine, whereas patients with hyperthyroidism were treated with propylthiouracil. Plasma leptin levels were measured by a RIA method with a sensitivity of 0.5 µg/l. Leptin levels were significantly lower in patients with hypothyroidism before treatment (4.17±2.58 µg/l) than in patients with hyperthyroidism (6.80±4.3 µg/l; z= −2.06, p=0.037). Leptin levels were significantly higher in hyperthyroid patients than in the control group (3.71±1.69 µ/l, z= −2.44, p=0.014) whereas leptin levels in the hypothyroid patients were not significantly different from those in control subjects (z= −0.16, p=0.87). Restoration of euthyroid state was not associated with a significant change in leptin levels either in the hypothyroid (from 4.17±2.58 to 5.22±3.4 µg/l; z= −1,74, p=0.08) or in the hyperthyroid group (from 6.80±4.37 µg/l to 7.93±6.25 µg/l z= −0.89, p=0.37), although a tendency for leptin to increase was observed in both groups. There was no correlation between plasma leptin and FT3, FT4, TSH, or BMI either before or after therapy in both groups. Leptin levels were significantly correlated with BMI in the control group (r= −0.53, p=0.018). We conclude that plasma leptin levels are increased in hyperthyroidism and unchanged in hypothyroidism. Furthermore, our study demonstrates that mean plasma leptin levels are not influenced by short term restoration of euthyroidism in both hypothyroidism and hyperthyroidism, although an effect of long-term treatment may not be excluded.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Campfield L.A., Smith F.J., Guisez Y., Devos R., Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269: 546, 1995.
Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannessian J.P., Marco C.C., Mckee L.J., Bauer T.L. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N. Engl. J. Med. 334: 292, 1996.
Mantzoros C.S., Qu D., Frederich R., Susulic V.S., Lowel B.B., Maratos-Flier E., Flier J.S. Activation of β3 adrenergic receptors suppresses leptin expression and mediates a leptin independent suppression of food intake in mice. Diabetes 45: 909, 1996.
Slieker L.J., Sloop K.W., Surface P.L., Kriauciunas A., LaQuier F., Manetta J., Bue-Valleskey J., Stephens T.N. Regulation of expression of ob RNA and protein by glucocorticoids and cAMP. J. Biol. Chem. 271: 5301, 1996.
Silva J.E. Catecholamines and the sympathoadrenal system in thyrotoxicosis. In: Braverman L.E., Utiger R.D., (Eds.), Werner and Ingbar’s the thyroid. Lippincott-Raven, Philadelphia-New York, 1996, p. 661.
Danforth E. The role of thyroid hormones and insulin in the regulation of energy metabolism. Am. J. Clin. Nutr. 38: 1006, 1983.
Danforth E., Burger A. The role of thyroid hormones in the control of energy expenditure. Clin. Endocrinol. Metab. 13: 581, 1984.
Fain J.N., Coronel E.C., Beauchamp M.J., Bahouth S.N. Expression of leptin and beta-3-adrenergic receptors in rat adipose tissue in altered thyroid state. Biochem. J. 322: 145, 1997.
Yoshida T., Monkawa T., Hayashi M., Saruta T. Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 232: 822, 1997.
Mantzoros C.S., Rosen H.N., Greenspan S.L., Flier J.S., Moses A.C. Short-term hyperthyroidism has no effect on leptin levels in man. J. Clin. Endocrinol. Metab. 82: 497, 1997.
Valcavi R., Zini M., Peino R., Casanueva F.F., Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J. Clin. Endocrinol. Metab. 82: 1632, 1997.
Rohner-Jeanrenaud F., Jeanrenaud B. Obesity, leptin, and the brain. N. Engl. J. Med. 334: 324, 1996.
Al-Adsani H., Hoffer L.J., Silva J.E. Resting energy expenditure is sensitive to small dose changes in patients on chronic thyroid hormone replacement. J. Clin. Endocrinol. Metab. 82: 1118, 1997.
Legradi G., Emerson C.H., Ahima R.S., Flier J.S., Lechan R.M. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138: 2569, 1997.
Sreenan S., Caro J.F., Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 7: 407, 1997.
Saad M.F., Dameni S., Gingerich M., Riad-Gabriel M.G., Khad A., Boyadjian R., Jinagouda S.D., El-Tavil K., Rude R.K., Kamdar V. Sexual dimorphism in plasma leptin concentration. J. Clin. Endocrinol. Metab. 82: 579, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ozata, M., Ozisik, G., Bingol, N. et al. The effects of thyroid status on plasma leptin levels in women. J Endocrinol Invest 21, 337–341 (1998). https://doi.org/10.1007/BF03350767
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03350767